OMEPRAZOLE MAGNESIUM (omeprazole magnesium) by Design Pharmaceuticals is compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the h/k atpase enzyme system at the secretory surface of the gastric parietal cell. Approved for heartburn, other symptoms associated with gerd for up to 4 weeks in patients 1 year of age, older. First approved in 2015.
Drug data last refreshed 18h ago
compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H/K ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the gastric mucosa, omeprazole has…
Worked on OMEPRAZOLE MAGNESIUM at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition
Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition
Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Conditions
Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions
Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)